The use of molecular markers to predict for optimal cytoreduction in ovarian cancer

被引：0
|
作者：
Fuh, K. [1 ]
Kiet, T. [1 ]
Chen, L. [1 ]
Sherman, A. [1 ]
Kapp, D. [2 ]
Chan, J. [1 ]
机构：
[1] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[2] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷
关键词：
D O I：
10.1016/j.ygyno.2011.12.030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
29
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [1] The use of molecular markers to predict for optimal cytoreduction in ovarian cancer
    Fuh, K.
    Kiet, T. K.
    Chen, L.
    Brooks, R. A.
    Sherman, A. E.
    Kapp, D. S.
    Chan, J. K.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 436 - 437
  • [2] Chemokine Ligand 5 to Predict Optimal Cytoreduction in Ovarian Cancer
    Hidayat, Yudi Mulyana
    Munizar
    Harsono, Ali Budi
    Winarno, Gatot Nyarumenteng Adhipurnawan
    Hasanuddin
    Salima, Siti
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2020, 13 : 1201 - 1206
  • [3] HOW TO PREDICT OPTIMAL CYTOREDUCTION IN ADVANCED OVARIAN CANCER: A CT SCAN MODEL
    Sangiorgio, V.
    Tripodi, E.
    Daniele, A.
    Modaffari, P.
    Perotto, S.
    Ferrero, A.
    Menato, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [4] Defining the Ca 125 value to predict optimal cytoreduction in patients with epithelial ovarian cancer
    Bueno, Gonzalo Arturo Medina
    Barra, Rocko Karina Quinonez
    Ramos, Deyne Maribel Ticona
    REVISTA PERUANA DE GINECOLOGIA Y OBSTETRICIA, 2023, 69 (04):
  • [5] SPLENECTOMY FOR OPTIMAL CYTOREDUCTION IN OVARIAN-CANCER
    MALFETANO, JH
    GYNECOLOGIC ONCOLOGY, 1986, 24 (03) : 392 - 394
  • [6] The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer
    Barlow, TS
    Przybylski, M
    Schilder, JM
    Moore, DH
    Look, KY
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (02) : 496 - 500
  • [7] Optimal cytoreduction for advanced epithelial ovarian cancer: A commentary
    Eisenkop, Scott M.
    Spirtos, Nick M.
    Lin, Wei-Chien Michael
    GYNECOLOGIC ONCOLOGY, 2006, 103 (01) : 329 - 335
  • [8] Immune signatures predictive of optimal cytoreduction in ovarian cancer
    Simons, E.
    Kiet, T.
    Amanam, I.
    Ho, M.
    Fuh, J.
    Fuh, K.
    Kapp, D.
    Odunsi, K.
    Chan, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S46 - S46
  • [9] Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer
    Cardillo, Nicholas
    Devor, Eric J.
    Pedra Nobre, Silvana
    Newtson, Andreea
    Leslie, Kimberly
    Bender, David P.
    Smith, Brian J.
    Goodheart, Michael J.
    Gonzalez-Bosquet, Jesus
    CANCERS, 2022, 14 (14)
  • [10] PREOPERATIVE AND LAPAROSCOPIC EVALUATION FOR OPTIMAL CYTOREDUCTION IN ADVANCED OVARIAN CANCER
    Fagotti, A.
    Vizzielli, G.
    Tortorella, L.
    Fanfani, F.
    Costantini, B.
    Ferrandina, G.
    Gallotta, V.
    Alletti, S. Gueli
    Iodice, R.
    Scambia, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
12345